Five Prime Therapeutics
Why Robinhood?
You can watch FPRX and buy or sell other stocks, ETFs, and their options commission-free!About FPRX
Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150.
FPRX Key Statistics
Stock Snapshot
The current Five Prime Therapeutics(FPRX) stock price is $38.00, with a market capitalization of 1.77B. The stock trades at a price-to-earnings (P/E) ratio of -14.16.
On 2026-05-15, Five Prime Therapeutics(FPRX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.11M.
The stock's 52-week range extends from a low of $2.64 to a high of $38.90.
The stock's 52-week range extends from a low of $2.64 to a high of $38.90.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.